ARCHIVES

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

This article is from The Cancer Letter archive.

Vol. 35 No. 31 | August 7, 2009

Download PDF Visit The Full Archive

Related Articles

House Subcommittee Adds $30 Billion to NCI ’79 Budget

May 12, 1978

NCI Advisors Approve Three New Grant Programs; RFA, PA Available.

July 5, 2002

Iressa Authorization In Europe Clarifies Differences Between U.S., E.U. Standards

July 31, 2009

NCI Staff Suggest New Community Oncology, Pain Control, Nurse, Pathology Center Projects

May 13, 1977

In Brief: Angel Bradley To Head NCAB Subcommittee UCLA, USC Join In CCRU Grant Application

September 3, 1982

Nominations Sought for Disney-ACS Research Professor

November 19, 1993